Small Cell Lung Cancer
Showing NaN - NaN of 28
Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, Placebo)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Small Cell Lung Cancer
- Tarlatamab
- Placebo
-
Minneapolis, Minnesota
- +124 more
Oct 31, 2023
Small Cell Lung Cancer Trial in Worldwide (biological, drug, radiation)
Recruiting
- Small Cell Lung Cancer
- Pembrolizumab 200 mg
- +8 more
-
Chandler, Arizona
- +170 more
Feb 2, 2023
Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab, MK-4830, MK-5890)
Recruiting
- Small Cell Lung Cancer
- Pembrolizumab
- +6 more
-
Gilbert, Arizona
- +48 more
Jan 19, 2023
Small Cell Lung Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Carboplatin)
Active, not recruiting
- Small Cell Lung Cancer
- Tiragolumab
- +4 more
-
Lone Tree, Colorado
- +123 more
Dec 21, 2022
Small Cell Lung Cancer Trial in Worldwide (Irinotecan liposome injection, Topotecan)
Active, not recruiting
- Small Cell Lung Cancer
- Irinotecan liposome injection
- Topotecan
-
Denver, Colorado
- +117 more
Nov 22, 2022
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)
Recruiting
- Clear Cell Renal Cell Cancer
- +8 more
- AZD8701
- Durvalumab
-
La Jolla, California
- +22 more
Aug 12, 2022
Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Carboplatin)
Terminated
- Small Cell Lung Cancer
- Trilaciclib
- +4 more
-
Beverly Hills, California
- +44 more
Apr 8, 2022
Small Cell Lung Cancer Trial in Spain (BMS-986012, Cisplatin, Etoposide)
Active, not recruiting
- Small Cell Lung Cancer
- BMS-986012
- +4 more
-
Barcelona, Spain
- +3 more
Apr 25, 2022
Small Cell Lung Cancer Trial in Worldwide (LY3295668 Erbumine)
Completed
- Small Cell Lung Cancer
- LY3295668 Erbumine
-
Fayetteville, Arkansas
- +39 more
Jul 30, 2021
Small Cell Lung Cancer Trial in Worldwide (Placebo for dexamethasone, Placebo for rovalpituzumab tesirine, Rovalpituzumab
Terminated
- Small Cell Lung Cancer
- Placebo for dexamethasone
- +3 more
-
Huntsville, Alabama
- +307 more
Jul 28, 2021
Small Cell Lung Cancer Trial in Worldwide (Rovalpituzumab tesirine, Topotecan, Dexamethasone)
Completed
- Small Cell Lung Cancer
- Rovalpituzumab tesirine
- +2 more
-
Huntsville, Alabama
- +194 more
Feb 19, 2021
Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer Trial in Worldwide (Ipilimumab, Nivolumab)
Unknown status
- Limited Stage Small Cell Lung Cancer
- Small Cell Lung Cancer
-
Bendigo, Australia
- +60 more
Feb 5, 2021
Small Cell Lung Cancer Trial in Worldwide (Dinutuximab, Irinotecan, Topotecan)
Completed
- Small Cell Lung Cancer
- Dinutuximab
- +2 more
-
Anchorage, Alaska
- +225 more
Nov 12, 2020
Small Cell Lung Cancer Trial in Worldwide (Carboplatin, Placebo, Trilaciclib)
Small Cell Lung Cancer Trial in Worldwide (Ipilimumab, Nivolumab, Rovalpituzumab tesirine)
Small Cell Lung Cancer Trial in Worldwide (Veliparib, Carboplatin, Etoposide)
Small Cell Lung Cancer Trial in Worldwide (Prexasertib)
Completed
- Small Cell Lung Cancer
-
Fayetteville, Arkansas
- +40 more
Mar 12, 2020
NSCLC, Squamous NSCLC, NSCLC Trial in Worldwide (Lucitanib)
Terminated
- Non-Small Cell Lung Cancer
- +8 more
-
Los Angeles, California
- +18 more
Jul 22, 2019
Small Cell Lung Cancer Trial in Worldwide (Alisertib, Placebo, Paclitaxel)
Small Cell Lung Cancer Trial in Worldwide (IMGN901, Carboplatin and Etoposide)
Terminated
- Small Cell Lung Cancer
- IMGN901
- Carboplatin and Etoposide
-
Tucson, Arizona
- +47 more
Dec 19, 2017